AKT1 and triple-negative breast carcinoma: For example, He et al. established a FRET biosensor-based high throughput imaging approach to determine Extracellular Signal-Regulated Kinase (ERK) and AKT serine/threonine kinase (Akt) activity in triple-negative breast cancer (TNBC) cell lines (He et al., 2019).